|
WO2014105870A1
|
|
Enhancing health in mammals using telomerase reverse transcriptase gene therapy
|
|
US2006154266A1
|
|
Assays for TERT promoter modulatory agents using a telomerase structural RNA component
|
|
US7279328B1
|
|
Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
|
|
AU2002323137A1
|
|
Methods and compositions for use in selectively producing a protein in telomerase expressing cells
|
|
US7211435B2
|
|
Telomerase expression repressor proteins and methods of using the same
|
|
AU2002256512A1
|
|
Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
|
|
AU2002308665A1
|
|
Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
|
|
AU2002254132A1
|
|
Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
|
|
US6686159B2
|
|
Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
|
|
AU8833201A
|
|
Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
|
